Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: a sub-study of EORTC 10994/BIG 1-00 phase III trial
Nom du journal : Eur J Cancer
Année : 2015
Volume : 51
Page de départ : 301
Page de fin : 309